Transcultural Validation of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) in French: The PASIPD-Fr

NCT04061616 | Completed

• 1 other identifier: PASIPD-Fr
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) is a scale that has been developped and validated in English to quantify the level of physical activity for people with physical disabilities. The investigators aimed to translate and validate a French transcultural version of the PASIPD (PASIPD-Fr) through a rigourous process following international recommendations for cross-cultural translation and adaptation of questionnaires.

Conditions

Physical Disability; Neurological Diseases or Conditions

Outcome Measures

Primary Outcomes (3)

• Criterion validity (correlation)

  The Dijon PAS assesses the level of physical activity in the general population, the elderly and is recommended after a stroke. To test the criterion validity of the PASIPD-Fr, the investigators calculated the Pearson correlation coefficient (PCC) between the scores for the PASIPD-Fr and the Dijon PAS.

  Both scales (PASIPD-Fr and Dijon PAS) were filled-out in a single point of time within a period of time of 12 months (study time frame)

• Criterion validity (discrimination)

  The Dijon PAS assesses the level of physical activity in the general population, the elderly and is recommended after a stroke. To test the criterion validity of the PASIPD-Fr, the investigators used the repeated measures ANOVA to check for differences between inactive, moderately active ang highly active individuals (respectively score \<10, 10-20 and \>20 over 30 on Dijon PAS) with Tukey post-hoc tests.

  Both scales (PASIPD-Fr and Dijon PAS) were filled-out in a single point of time within a period of time of 12 months (study time frame)

• Test-retest reliability

  The investigators calculated the intraclass coefficient (ICC) between 2 completions of the PASIPD-Fr questionnaire at a 2-week interval.

  The PASIPD-Fr was administered twice at a 2-week interval within a period of time of 12 months (study time frame)

Secondary Outcomes (5)

• Construct validity 10TMWT

  Both PASIPD-Fr questionaire and 10MWT test were assessed in a single point of time within a period of time of 12 months (study time frame)

• Construct validity ABC-S

  Both PASIPD-Fr questionaire and ABC-S scale were filled-out in a single point of time within a period of time of 12 months (study time frame)

• Construct validity HAD

  Both PASIPD-Fr questionaire and HAD scale were filled-out in a single point of time within a period of time of 12 months (study time frame)

• Construct validity MOS SF12

  Both PASIPD-Fr questionaire and MOS SF12 scale were filled-out in a single point of time within a period of time of 12 months (study time frame)

• Internal consistency

  The PASIPD-Fr scale was filled-out in a single point of time within a period of time of 12 months (study time frame)

Study Arms (1)

Participants

EXPERIMENTAL

All the participants volunteer to participate to the study that were included.

Behavioral: PASIPD-Fr

Interventions

PASIPD-Fr BEHAVIORAL

Fill-out the PASIPD-Fr self questionaire twice (2 completions at a 2-week interval)

Participants

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient who received research information
• Patient affiliated to a social security system
• Patient over 18 years of age
• Patients with physical disabilities (Act No. 2005-102 on equal rights and opportunities)
• Individuals with the following disease: stroke survivors, multiple sclerosis, neuromuscular disease and idiopathic Parkinson's disease

You may not qualify if:

• Patient not affiliated to a social security system.
• Patients under guardianship or curators or protection of justice.
• Lack of informed information about the study
• Alteration of higher functions or sensory disturbance making it impossible to understand and adhere to the research protocol
• A severe medical condition that significantly alters functional abilities (severe heart failure, respiratory failure, unstable metabolic disorders such as active renal failure) and involves a life-threatening condition in the short to medium term (progressive neoplastic pathology, unstable systemic disease).

Sponsors & Collaborators

• University Hospital, Caen: lead

Study Sites (1)

CHU Caen Normandie

Caen, 14000, France

Location

Related Publications (1)

• Meunier P, Joussain C, Gremeaux V, Carnet D, Bastable P, Ruet A, Drigny J. Transcultural adaptation and validation of a French version of the Physical Activity Scale for Individuals with Physical Disabilities (PASIPD-Fr). Ann Phys Rehabil Med. 2021 Jul;64(4):101423. doi: 10.1016/j.rehab.2020.07.006. Epub 2020 Aug 26. No abstract available.

  PMID: 32763488 RESULT

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 16, 2019
• First Posted: August 20, 2019
• Study Start: July 1, 2017
• Primary Completion: February 1, 2019
• Study Completion: August 1, 2019
• Last Updated: February 17, 2026

Record last verified: 2019-08

Locations

FR (1)